What is Mounjaro?
Mounjaro is a medication used to improve blood sugar control in adults with type 2 diabetes [1]. It is a dual GIP and GLP-1 receptor agonist [1].
What are the ingredients in Mounjaro?
Mounjaro contains tirzepatide as its active ingredient [1].
How is Mounjaro administered?
Mounjaro is administered via subcutaneous injection [1].
What is the typical dosage for Mounjaro?
The starting dosage for Mounjaro is 2.5 mg once weekly. Doses can be increased by 2.5 mg every four weeks as needed, with a maximum recommended dose of 15 mg once weekly [1].
What is the price of Mounjaro?
The price of Mounjaro can vary depending on the dosage and pharmacy. For example, a 2.5 mg dose might cost around $1,000 to $1,100 for a month's supply, while higher dosages like 15 mg could be closer to $1,100 to $1,200 for a month's supply [2]. These prices are based on cash prices and do not reflect potential insurance coverage or discount programs [2].
How can I find Mounjaro discounts?
Patients may be able to find discounts or savings programs for Mounjaro. Eli Lilly and Company, the manufacturer, offers a savings card program that can potentially reduce out-of-pocket costs for eligible commercially insured patients [3]. It is advisable to check the manufacturer's website or speak with a pharmacist for current offers and eligibility requirements [3].
Does insurance cover Mounjaro?
Insurance coverage for Mounjaro varies by plan. Some insurance providers may cover Mounjaro, while others may require prior authorization or have specific criteria for coverage [3]. Patients are encouraged to verify their specific insurance benefits and discuss coverage options with their healthcare provider and insurance company [3].
What are the side effects of Mounjaro?
Common side effects of Mounjaro include nausea, vomiting, diarrhea, constipation, and abdominal pain [1]. More serious side effects can occur, and patients should seek medical attention if they experience severe reactions [1].
When does the Mounjaro patent expire?
Information on Mounjaro's patent expiration is available through specialized resources. DrugPatentWatch.com tracks pharmaceutical patents, providing details on patent filings and expiration dates for various medications, including Mounjaro [4].
What are the alternatives to Mounjaro for type 2 diabetes?
Other medications for type 2 diabetes include GLP-1 receptor agonists like semaglutide and liraglutide, as well as DPP-4 inhibitors, SGLT2 inhibitors, and insulin [5]. The choice of medication depends on individual patient needs, medical history, and treatment goals [5].
Sources
1. https://www.mounjaro.com/
2. https://www.goodrx.com/mounjaro
3. https://www.mounjaro.com/savings-and-support
4. https://drugpatentwatch.com/
5. https://www.niddk.nih.gov/health-information/diabetes/overview-diabetes/type-2-diabetes/managing-type-2-diabetes